Westhampton Capital, LLC Bristol Myers Squibb CO Transaction History
Westhampton Capital, LLC
- $190 Million
- Q4 2024
A detailed history of Westhampton Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Westhampton Capital, LLC holds 27,417 shares of BMY stock, worth $1.73 Million. This represents 0.81% of its overall portfolio holdings.
Number of Shares
27,417
Previous 27,217
0.73%
Holding current value
$1.73 Million
Previous $1.41 Million
10.09%
% of portfolio
0.81%
Previous 0.72%
Shares
18 transactions
Others Institutions Holding BMY
# of Institutions
2,761Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$12 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$10 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$6.06 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$6 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.81 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $134B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...